Latest Articles

Article Type

You have access
Correction to “(3S)-3-(2,3-difluorophenyl)-3-methoxypyrrolidine (IRL752) – a Novel Cortical-Preferring Catecholamine Transmission – and Cognition-Promoting Agent”
Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 531-532; DOI: https://doi.org/10.1124/jpet.120.000304
You have access
Celastrol dilates and counteracts ethanol-induced constriction of cerebral arteries
Kelsey Cleland North, Alexandria V. Slayden, Steven Mysiewicz, Anna N. Bukiya and Alex M. Dopico

Journal of Pharmacology and Experimental Therapeutics August 29, 2020, JPET-AR-2020-000152; DOI: https://doi.org/10.1124/jpet.120.000152
You have access
Association between N-desmethylclozapine and clozapine-induced sialorrhea: Involvement of increased nocturnal salivary secretion via muscarinic receptors by N-desmethylclozapine
Shuhei Ishikawa, Masaki Kobayashi, Naoki Hashimoto, Hideaki Mikami, Akihiko Tanimura, Katsuya Narumi, Ayako Furugen, Ichiro Kusumi and Ken Iseki

Journal of Pharmacology and Experimental Therapeutics August 29, 2020, JPET-AR-2020-000164; DOI: https://doi.org/10.1124/jpet.120.000164
You have access
A Novel Potent and Selective Histamine H3 Receptor Antagonist Enerisant: In Vitro Profiles, In Vivo Receptor Occupancy, Wake-Promoting and Pro-cognitive Effects in Rodents
Noriko Hino, Toshiyuki Marumo, Makiko Kotani, Toshiharu Shimazaki, Ayaka Kaku-Fukumoto, Hirohiko Hikichi, Jun-ichi Karasawa, Yasumitsu Tomishima, Hiroko Komiyama, Emi Tatsuda, Dai Nozawa, Toshio Nakamura and Shigeyuki Chaki

Journal of Pharmacology and Experimental Therapeutics August 29, 2020, JPET-AR-2020-000185; DOI: https://doi.org/10.1124/jpet.120.000185
You have access
Correction to “Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222”
Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 499; DOI: https://doi.org/10.1124/jpet.119.261800err
You have access
Correction to “Aripiprazole Cytotoxicity Coincides with Activation of the Unfolded Protein Response in Human Hepatic Cells”
Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 529; DOI: https://doi.org/10.1124/jpet.119.264481err
You have access
Correction to “A Mechanistic and Translational Pharmacokinetic-Pharmacodynamic Model of Abicipar Pegol and Vascular Endothelial Growth Factor Inhibition”
Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 530; DOI: https://doi.org/10.1124/jpet.120.000210
Open Access
Cell-Based No-Wash Fluorescence Assays for Compound Screens Using a Fluorescence Cytometry Plate Reader
Kirill Gorshkov, Manisha Pradhan, Miao Xu, Shu Yang, Emily M. Lee, Catherine Z. Chen, Min Shen and Wei Zheng

Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 500-511; DOI: https://doi.org/10.1124/jpet.120.265207
You have access
CD13 Induces Autophagy to Promote Hepatocellular Carcinoma Cell Chemoresistance Through the P38/Hsp27/CREB/ATG7 Pathway
Yan Zhao, Huina Wu, Xiaoyan Xing, Yuqian Ma, Shengping Ji, Xinyue Xu, Xin Zhao, Sensen Wang, Wenyan Jiang, Chunyan Fang, Lei Zhang, Fang Yan and Xuejian Wang

Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 512-520; DOI: https://doi.org/10.1124/jpet.120.265637
You have access
Topical Application of ASN008, a Permanently Charged Sodium Channel Blocker, Shows Robust Efficacy, a Rapid Onset, and Long Duration of Action in a Mouse Model of Pruritus
Roshni Ramachandran, Scott K. Thompson, Shelle Malkmus, Tsutomu Mieda, Jun-Hsiang Lin, Sandeep Gupta and Tony L. Yaksh

Journal of Pharmacology and Experimental Therapeutics September 2020, 374 (3) 521-528; DOI: https://doi.org/10.1124/jpet.120.265074

Main menu

User menu

Search

Latest Articles

Pages

Navigate

More Information

ASPET's Other Journals